New targeted treatment for prostate cancer
April 18th, 2010 Posted in radiation therapyUniversity of Cincinnati announced that its researchers will investigate, with a new partnership with Areva Med, the use of a new drug in stopping the growth of prostate cancer tumors. In the study, researchers will test the efficacy of a new agent targeted against a specific protein on the surface of the tumor.
The future study leader says previous radiation therapy targeting these proteins has been shown to inhibit tumor growth in several animal models. UC’s study will be the first to explore this approach for prostate tumors. In the work, researchers will bind the isotope 212-lead to an antibody targeting one of these proteins.